PULMONARY EMBOLISM
Clinical trials for PULMONARY EMBOLISM explained in plain language.
Never miss a new study
Get alerted when new PULMONARY EMBOLISM trials appear
Sign up with your email to follow new studies for PULMONARY EMBOLISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New tech targets deadly lung clots with lower bleeding risk
Disease control TerminatedThis study is testing a new, lower-dose method to treat serious blood clots in the lungs (pulmonary embolism). Doctors use a catheter and ultrasound waves to deliver a small dose of a clot-busting drug directly to the clot. The goal is to clear the clot and improve heart function…
Matched conditions: PULMONARY EMBOLISM
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Apr 03, 2026 19:47 UTC
-
Trial tests gentler breathing aid for dangerous lung clots
Disease control OngoingThis study compares two non-invasive methods to help patients with pulmonary embolism (lung clots) breathe better. It tests whether a high-flow nasal cannula (gentle, humidified oxygen) works as well as or better than non-invasive ventilation (a mask with pressure) at helping pat…
Matched conditions: PULMONARY EMBOLISM
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Personalized math could speed up blood clot treatment
Disease control OngoingThis study is testing if a personalized calculation for the starting dose of the blood thinner heparin works better than the standard one-size-fits-all approach. Researchers will compare how quickly patients with blood clots or certain heart conditions reach their target blood-th…
Matched conditions: PULMONARY EMBOLISM
Phase: PHASE4 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New device tested to break up dangerous lung clots
Disease control OngoingThis study compares two treatments for serious lung blood clots (pulmonary embolism). Researchers want to see if adding a special ultrasound device to standard blood thinners works better than blood thinners alone. The device delivers clot-dissolving medicine directly to the clot…
Matched conditions: PULMONARY EMBOLISM
Phase: PHASE4 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New device aims to pull dangerous clots from lungs without surgery
Disease control OngoingThis study is testing a medical device called the Vertex Pulmonary Embolectomy System to see if it can safely remove blood clots from the lungs of people with a serious type of pulmonary embolism. The device is inserted into blood vessels to physically pull out the clots, aiming …
Matched conditions: PULMONARY EMBOLISM
Phase: NA • Sponsor: Jupiter Endovascular • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Monthly shot aims to outperform daily injections for Cancer-Related blood clots
Disease control OngoingThis study is testing if a new monthly injection (abelacimab) works better and is safer than a standard daily injection (dalteparin) for preventing dangerous blood clots from coming back. It is for adults with specific cancers of the stomach, intestines, or urinary system who hav…
Matched conditions: PULMONARY EMBOLISM
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New device aims to suction deadly lung clots
Disease control OngoingThis study is testing a new medical device called the Aventus Thrombectomy System. It is designed to physically remove dangerous blood clots from the lungs of patients with a sudden, severe pulmonary embolism. The trial will enroll 130 adults to see if the procedure is safe and e…
Matched conditions: PULMONARY EMBOLISM
Phase: NA • Sponsor: Inquis Medical, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Doctors test custom plans to stop deadly blood clots from coming back
Disease control OngoingThis study aims to find the best personalized treatment plan for people who have had their first dangerous blood clot (like a deep vein thrombosis or pulmonary embolism). Researchers will use a simple cheek swab and questionnaire to estimate each patient's risk of having another …
Matched conditions: PULMONARY EMBOLISM
Phase: NA • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC
-
Massive 21,000-Person study tracks hidden causes of deadly blood clots
Knowledge-focused OngoingThis study aims to understand what causes dangerous blood clots in the lungs (pulmonary embolism) and legs (deep vein thrombosis). Researchers are following over 21,000 African American and white adults who were already part of two large heart health studies. They are collecting …
Matched conditions: PULMONARY EMBOLISM
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Gas test for clot crisis
Knowledge-focused TerminatedThis study aimed to understand if a gas called inhaled nitric oxide (iNO) could help improve heart and lung function in patients with serious, life-threatening blood clots in the lungs (pulmonary embolism). It planned to enroll about 20 patients at UCLA Medical Center and measure…
Matched conditions: PULMONARY EMBOLISM
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Finger cuff could predict heart failure risk from deadly lung clots
Knowledge-focused TerminatedThis study aimed to test if a non-invasive finger-cuff device could safely and effectively monitor heart function in real-time for patients hospitalized with serious pulmonary embolism (a dangerous lung blood clot). The goal was to see if the device's readings could help doctors …
Matched conditions: PULMONARY EMBOLISM
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Young blood clot survivors struggle to breathe during exercise
Knowledge-focused OngoingThis study aims to understand why some young people have trouble breathing and exercising after their first serious blood clot in the leg or lung. Researchers will follow 115 participants, aged 8 to 21, for a year, measuring their heart, lung, and muscle function during exercise …
Matched conditions: PULMONARY EMBOLISM
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC